During the past decade, Fort Smith Lung Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fort Smith Lung Center" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fort Smith Lung Center" are "Venous Thrombosis" (3 trials) and "Pulmonary Embolism" (1 trials). Many other conditions were trialed in "Fort Smith Lung Center" in a lesser frequency.

Most popular intervention types in "Fort Smith Lung Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Enoxaparin" (2 trials), "Placebo" (1 trials), "Placebo for apixaban" (1 trials) and "Placebo for enoxaparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fort Smith Lung Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fort Smith Lung Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fort Smith Lung Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fort Smith Lung Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".